CNWM
CVS icon

Clay Northam Wealth Management’s CVS Health CVS Stock Holding History

Clay Northam Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,845
Closed -$227K – 88
2024
Q1 		$227K Hold
2,845
– – 0.18% 78
2023
Q4 		$225K Buy
+2,845
New +$202K 0.2% 73
2023
Q2 		– Sell
-2,845
Closed -$211K – 79
2023
Q1 		$211K Hold
2,845
– – 0.22% 74
2022
Q4 		$265K Hold
2,845
– – 0.31% 59
2022
Q3 		$271K Hold
2,845
– – 0.34% 60
2022
Q2 		$264K Hold
2,845
– – 0.33% 60
2022
Q1 		$288K Sell
2,845
-50
-2% -$5.25K 0.29% 61
2021
Q4 		$299K Buy
+2,895
New +$268K 0.28% 68

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clay Northam Wealth Management's CVS Position: Q2 2024 in Review

Clay Northam Wealth Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,845 shares — an estimated $227K sold.

Clay Northam Wealth Management first reported a position in CVS in Q4 2021 and held it in 8 quarters. The position peaked at $299K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Clay Northam Wealth Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Clay Northam Wealth Management sold 2,845 CVS Health shares in Q2 2024, an estimated $227K.
  • Clay Northam Wealth Management first reported a position in CVS Health in Q4 2021 and held it in 8 quarters.
  • Clay Northam Wealth Management's CVS Health position peaked at $299K in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Clay Northam Wealth Management's 13F filing for Q2 2024, filed 19 Jul 2024.